Why BridgeBio Pharma Shares Are Rising
BridgeBio Pharma Inc (NASDAQ: BBIO) is trading higher Tuesday as the stock rebounds after falling on Monday.
25 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze.
Where BridgeBio Pharma Stands With Analysts
Within the last quarter, BridgeBio Pharma (NASDAQ:BBIO) has observed the following analyst ratings:
10 Biggest Price Target Changes For Tuesday
Argus Research raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,010 to $1,313. Tesla shares rose 1.8% to $1,113.84 in pre-market trading.
SVB Leerink Maintains Outperform on BridgeBio Pharma, Lowers Price Target to $24
SVB Leerink analyst Mani Foroohar maintains BridgeBio Pharma (NASDAQ:BBIO) with a Outperform and lowers the price target from $66 to $24.
51 Biggest Movers From Yesterday
Gainers
Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.64% to 36,181.37 while the NASDAQ rose 1.19% to 15,838.88. The S&P also rose, gaining 1.07% to 4,776.31.
Mid-Day Market Update: Nasdaq Rises 1%; BridgeBio Pharma Shares Plunge
Midway through trading Monday, the Dow traded up 0.54% to 36,146.21 while the NASDAQ rose 1.04% to 15,815.70. The S&P also rose, gaining 0.87% to 4,766.92.